Understanding COVID-19 Origins First Step to Treating Cases, Stopping Spread

Sbarro Health Research Organization (SHRO)

Newswise — “The new virus originating from Wuhan is the third coronavirus that has made the ‘jump’ from animals to humans,” explains Enrico Bucci, Ph.D., professor and research scientist at the Sbarro Health Research Organization (SHRO), at Temple University in Philadelphia. “We witnessed SARS, which infected 8,000 people between 2002 and 2003 and killed 775; and then the Middle East coronavirus, MERS, which from 2012 to 2019 counted 2,500 cases and 858 deaths, mainly in the Arabian Peninsula,” says Bucci. 

Bucci is part of an international team of clinicians that has published an editorial in the Journal of Thoracic Oncology, titled “Coronaviruses: Facts, Myths and Hypotheses.” The editorial focuses on several challenges for the international public health community attempting to halt the spread of the disease. 

The novel coronavirus is called severe acute respiratory syndrome coronavirus 2, or Sars-CoV-2. The disease it causes is called COVID-19 (“CO” corona, “VI” viruses, “D” disease and “19” indicates the year in which it occurred). The most common symptoms include fever, cough, breathing difficulties, and is therefore very similar to those of a seasonal flu; however, they are caused by different viruses, and in case of suspicion of Coronavirus, it is necessary to carry out laboratory tests to confirm the diagnosis.

Transmission occurs through direct contact or through respiratory droplets. The symptoms, similar to the flu, include fever and cough in less severe cases, and in more severe cases progress to pneumonia, acute respiratory syndrome, kidney failure, and potentially, death. 

“The worrying element of COVID-19 is the severity of the involvement of the lower respiratory tract, causing the cases of pneumonia that lead to the majority of deaths so far,” Bucci says.

“The goal of this article is to further advance medicine’s understanding of the origin, spread, and diagnosis and treatment of COVID-19," says Bucci. "In the end, the outcome of the study will benefit medicine and patients throughout the world, underscoring the value of team-work and international collaborations in medical research," concludes Bucci.

Virus incubation is defined as the period between the first infection and the development of clinical symptoms which is currently estimated between 2 and 11 days, up to a maximum of 14 days. These types of infections are more easily transmitted in closed areas and through close contacts, less than two meters away and the incidence of death is higher among patients over sixty-five and patients with chronic diseases, due to their lower ability to fight the infection. At present, more than 93,000 coronavirus positive cases have been confirmed worldwide, more than 50,000 of which have recovered. The virus spread quickly in China and on almost all continents. For comparison to other pandemics, the World Health Organization (WHO) reports that, worldwide, the influenza virus affects between 5 and 15% of the adult population every year (i.e. from 350 million to 1 billion people), characterized by an incidence range rises to 20-30% in children. These annual epidemics are estimated to result in about 3 to 5 million cases of severe illness, and about 290,000 to 650,000 respiratory deaths. To date the coronavirus mortality represents 3-4% (according to data derived from China). The Middle Eastern Coronavirus Epidemic, “Mers”, registered 2494 cases with 858 deaths, with a lethality rate of 34.4%. The Ebola virus, which is still ongoing in the Democratic Republic of the Congo, at present represents a public health emergency correlated to a lethality rate of around 50%. 

The coronavirus influenza treatment is similar to serious cases of flu, but specific drugs or vaccines do not yet exist. In addition, as well as for the flu, treatment does not include antibiotics because these drugs are only useful for bacterial complications.

About the Sbarro Health Research Organization

The Sbarro Health Research Organization (SHRO) is non-profit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. To learn more about the SHRO please visit www.shro.org




Filters close

Showing results

110 of 3821
Newswise: UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
Released: 28-Oct-2020 5:20 PM EDT
UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
UC Davis Health

UC Davis Health is one of only a handful of health systems in the U.S. to launch a Post-COVID-19 Clinic to care for long-haul COVID patients whose symptoms go on and on, sometimes for months, with no clear explanation or avenue for treatment.

Newswise: Most People Mount a Strong Antibody Response to 
SARS-CoV-2 That Does Not Decline Rapidly
Released: 28-Oct-2020 5:20 PM EDT
Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly
Mount Sinai Health System

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

Newswise: 45a1c2a0-c0a4-11ea-b53e-cb3f2ed770b1.jpg
Released: 28-Oct-2020 4:00 PM EDT
Investigator on the AtraZeneca vaccine trial will take questions at Live Event on Oct. 29, 3PM
Keck Medicine of USC

Dr. Edward Jones-Lopez, joins a Newswise Live Expert Panel on Thursday Oct. 29, from 3-4 PM EDT to discuss the AstraZenea COVID-19 vaccine trial.

Released: 28-Oct-2020 4:00 PM EDT
"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT
Newswise

"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT

Newswise: Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Released: 28-Oct-2020 2:15 PM EDT
Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Oak Ridge National Laboratory

A collaboration between the Department of Energy’s Oak Ridge National Laboratory and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.

Released: 28-Oct-2020 1:55 PM EDT
What EEGs tell us about COVID-19 and the brain
Baylor College of Medicine

Throughout the pandemic, healthcare workers have seen more than just the lungs affected by COVID-19. Doctors have reported neurological complications including stroke, headache and seizures, but the information is limited to a number of individual reports that are not reflective of a larger population.

Released: 28-Oct-2020 1:50 PM EDT
A new playbook: COVID-19, athletes' hearts and return to play
Massachusetts General Hospital

Reports have indicated that COVID-19 may cause heart damage in hospitalized patients with severe cases of the disease, but it's unclear whether cardiac injury also occurs in infected patients who are asymptomatic or experience only mild symptoms.

Newswise: 0815UCI20052-1069-768x512.jpg
Released: 28-Oct-2020 1:05 PM EDT
Antibody screening finds COVID-19 nearly 7 times more prevalent in O.C. than thought
University of California, Irvine

Irvine, Calif., Oct. 28, 2020 — Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent. Latino and low-income residents had the highest prevalence of SARS-CoV-02 antibodies with rates of 17 percent and 15 percent, respectively.

Released: 28-Oct-2020 1:05 PM EDT
Researchers find confusion over masks for wildfire, COVID-19 crises
Stanford School of Earth, Energy & Environmental Sciences

To mask or not to mask - and which mask to use? With public health guidance about masks in the United States confused by political hedging, clarity around mask use is increasingly important, especially as the western U.S. battles the twin crises of wildfire smoke and COVID-19.


Showing results

110 of 3821

close
1.14307